CBIO
NASDAQ · Biotechnology
Crescent Biopharma Inc
$17.55
+0.05 (+0.29%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+57.6% upside
Low Target
$15.31
Average Target
$27.66
High Target
$30.74
Current Price
$17.55
Current
$17.55
$17.55
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Scenario Analysis
Bear Case
$15.31
-12.8%
Low target
Base Case
$27.66
+57.6%
Avg target
Bull Case
$30.74
+75.2%
High target
Risk/Reward
5.9x
Highly favorable
Price in Context
52-Week High
$27.41
-36.0% from high
52-Week Low
$8.72
+101.3% from low
Target vs 52W High
$27.66
+0.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +190.0% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.4% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.7% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |